JAN (NYSE:JAN – Get Free Report) had its target price lowered by equities researchers at Scotiabank from $30.00 to $29.00 in a report issued on Thursday,Benzinga reports. The firm currently has a “sector outperform” rating on the stock. Scotiabank’s price objective points to a potential upside of 14.11% from the company’s previous close.
JAN has been the topic of several other research reports. Raymond James Financial began coverage on JAN in a report on Tuesday. They set a “strong-buy” rating and a $34.00 target price on the stock. JPMorgan Chase & Co. began coverage on JAN in a report on Tuesday, April 14th. They set an “overweight” rating and a $26.00 target price on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $30.00 target price on shares of JAN in a report on Friday, June 12th. The Goldman Sachs Group began coverage on JAN in a report on Tuesday, April 14th. They set a “neutral” rating and a $27.00 target price on the stock. Finally, Bank of America began coverage on JAN in a report on Tuesday, April 14th. They set a “buy” rating and a $29.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $29.17.
Check Out Our Latest Analysis on JAN
JAN Stock Down 0.5%
JAN (NYSE:JAN – Get Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $0.23 EPS for the quarter, hitting the consensus estimate of $0.23. The business had revenue of $200.35 million for the quarter, compared to the consensus estimate of $157.96 million. JAN has set its FY 2026 guidance at 0.930-0.970 EPS.
Insider Transactions at JAN
In related news, CEO Scott M. Brinker bought 100,000 shares of the business’s stock in a transaction on Monday, March 23rd. The shares were purchased at an average price of $20.00 per share, with a total value of $2,000,000.00. Following the completion of the purchase, the chief executive officer owned 100,000 shares of the company’s stock, valued at $2,000,000. This represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO Jeffrey H. Miller bought 7,500 shares of the business’s stock in a transaction on Monday, March 23rd. The stock was bought at an average cost of $20.00 per share, for a total transaction of $150,000.00. Following the purchase, the chief operating officer directly owned 7,500 shares of the company’s stock, valued at approximately $150,000. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have acquired 187,000 shares of company stock valued at $3,740,000. Corporate insiders own 3.00% of the company’s stock.
Key Headlines Impacting JAN
Here are the key news stories impacting JAN this week:
- Positive Sentiment: Raymond James upgraded JAN to “strong-buy,” which can attract new buyers and support the stock. Tickerreport.com
- Neutral Sentiment: The company’s recent quarterly results were solid, with EPS in line with expectations and revenue above estimates, giving investors a favorable backdrop ahead of the fiscal 2026 guidance range. MarketBeat JAN Stock Page
About JAN
Upon completion of this offering, we will be the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT whose entire portfolio is owned and operated under RIDEA structures. We have an initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. Our communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025.
Featured Stories
- Five stocks we like better than JAN
- The AI Trade Is Getting Harder to Pick, But These 3 ETFs Take a Different Route
- 3 Hotel REITs Poised to Benefit from the World Cup
- Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story
- 3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound
Receive News & Ratings for JAN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JAN and related companies with MarketBeat.com's FREE daily email newsletter.
